Clinical trials seek treatment for Tardive Dyskinesia
Three clinical trials seeking treatments for a neurological disorder known as Tardive Dyskinesia are currently seeking volunteers. The studies – Efficacy of Docosahexaenoic Acid on Tardive Dyskinesia, Safety and Efficacy of Avastrem (Pryidoxal 5’ –Phosphate) in the Treatment of Tardive Dyskinesia, and Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia – are supported by ClinicalTrials.gov, a service of the U.S. National Institutes of Health.